SCM
CBAY
Sio Capital Management’s Cymabay Therapeutics CBAY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-555,610
| Closed | -$3.48M | – | 57 |
|
|
2022
Q4 | $3.48M | Hold |
555,610
| – | – | 1.29% | 15 |
|
|
2022
Q3 | $1.95M | Hold |
555,610
| – | – | 0.62% | 22 |
|
|
2022
Q2 | $1.64M | Sell |
555,610
-6,729
| -1% | -$19.9K | 0.62% | 32 |
|
|
2022
Q1 | $1.75M | Hold |
562,339
| – | – | 0.58% | 37 |
|
|
2021
Q4 | $1.9M | Hold |
562,339
| – | – | 0.57% | 44 |
|
|
2021
Q3 | $2.05M | Hold |
562,339
| – | – | 0.65% | 43 |
|
|
2021
Q2 | $2.45M | Hold |
562,339
| – | – | 0.61% | 50 |
|
|
2021
Q1 | $2.55M | Sell |
562,339
-25,000
| -4% | -$113K | 0.52% | 58 |
|
|
2020
Q4 | $3.37M | Sell |
587,339
-571,897
| -49% | -$3.28M | 0.69% | 48 |
|
|
2020
Q3 | $8.39M | Sell |
1,159,236
-1,140,746
| -50% | -$8.26M | 1.66% | 18 |
|
|
2020
Q2 | $8.03M | Buy |
2,299,982
+2,167,508
| +1,636% | +$7.56M | 2.34% | 13 |
|
|
2020
Q1 | $196K | Buy |
+132,474
| New | +$196K | 0.07% | 62 |
|
|
2019
Q2 | – | Sell |
-239,827
| Closed | -$3.19M | – | 86 |
|
|
2019
Q1 | $3.19M | Buy |
239,827
+52,500
| +28% | +$697K | 0.86% | 40 |
|
|
2018
Q4 | $1.47M | Buy |
+187,327
| New | +$1.47M | 0.54% | 53 |
|
|
2017
Q4 | – | Sell |
-75,000
| Closed | -$605K | – | 62 |
|
|
2017
Q3 | $605K | Buy |
+75,000
| New | +$605K | 0.31% | 37 |
|
|
2015
Q1 | – | Sell |
-121,900
| Closed | -$1.2M | – | 36 |
|
|
2014
Q4 | $1.2M | Buy |
+121,900
| New | +$1.2M | 0.94% | 25 |
|